Краткий ответ У пациентов с хронической сердечной недостаточностью усиленная наружная контрпульсация увеличивает дистанцию теста шестиминутной ходьбы на 20–60%, а фракцию выброса левого желудочка — на 7,7–21,1%. Обзор У пациентов с хронической сердечной недостаточностью усиленная наружная контрпульсация была связана со значительным улучшением толерантности к физической нагрузке и систолической функции. Согласно нескольким исследованиям, дистанция теста шестиминутной ходьбы увеличивалась в лечебных группах примерно на 20–60% — с отдельными сообщениями об увеличении до 125,5% — а в одном метаанализе было отмечено абсолютное улучшение приблизительно на 84,8 метра. Параллельно, в группах лечения наблюдалось увеличение фракции выброса левого желудочка в диапазоне от примерно 7,7% до 21,1% (с одним сообщением о достижении примерно 23%), в то время как в контрольных группах улучшение обычно составляло от 5% до 8%. В большинстве протоколов использовался курс из 35 сеансов продолжительность
Краткий ответ
У пациентов с хронической сердечной недостаточностью усиленная наружная контрпульсация увеличивает дистанцию теста шестиминутной ходьбы на 20–60%, а фракцию выброса левого желудочка — на 7,7–21,1%.
Обзор
У пациентов с хронической сердечной недостаточностью усиленная наружная контрпульсация была связана со значительным улучшением толерантности к физической нагрузке и систолической функции.
Согласно нескольким исследованиям, дистанция теста шестиминутной ходьбы увеличивалась в лечебных группах примерно на 20–60% — с отдельными сообщениями об увеличении до 125,5% — а в одном метаанализе было отмечено абсолютное улучшение приблизительно на 84,8 метра. Параллельно, в группах лечения наблюдалось увеличение фракции выброса левого желудочка в диапазоне от примерно 7,7% до 21,1% (с одним сообщением о достижении примерно 23%), в то время как в контрольных группах улучшение обычно составляло от 5% до 8%. В большинстве протоколов использовался курс из 35 сеансов продолжительностью один час каждый с давлением накачивания манжет в
диапазоне 220–300 мм рт. ст., и улучшения были статистически значимыми
(p < 0,05 до p < 0,001) в большинстве исследований.
Методы
Мы проанализировали 40 источников из первоначального пула в 500, используя 8 критериев отбора. Каждая публикация была проверена на предмет 7 ключевых аспектов, которые имели наибольшее значение для цели исследования.
Список литературы
1. A. Akula, Heidi R. Grafft, Nadia Tak, Douglas A. Haberman, and Tahir Tak. “Enhanced External Counterpulsation Outcomes Study: Retrospective Analyses of Data Obtained from Patients at a Single Medical Center in the United States.” *International Journal of Angiology*, 2024. https://doi.org/10.1055/s-0044-1782657
2. A. Feldman, M. Silver, G. Francis, C. Abbottsmith, B. Fleishman, O. Soran, P. de Lame, and T. Varricchione. “Enhanced External Counterpulsation Improves Exercise Tolerance in Patients with Chronic Heart Failure.” *Journal of the American College of Cardiology*, 2006. https://doi.org/10.1016/J.JACC.2005.10.079
3. A. Feldman, M. Silver, G. Francis, P. de Lame, and W. Parmley. “Treating Heart Failure with Enhanced External Counterpulsation (EECP): Design of the Prospective Evaluation of EECP in Heart Failure (PEECH) Trial.” *Journal of Cardiac Failure*, 2005. https://doi.org/10.1016/J.CARDFAIL.2004.10.001
4. A. Gothwal, Parvesh Jaguri, P. Sidhu, and S. Mittal. “Improvement in Left Ventricular Systolic and Diastolic Functions with Enhanced External Counterpulsation in Patients with Heart Failure Is Sustained at One Year,” 2006. https://doi.org/10.1016/j.cardfail.2006.06.439
5. A. S. Lishuta, E. V. Privalova, and Y. Belenkov. “Enhanced External Counterpulsation in the Management of Patients with Ischemic Heart Failure: Long-Term Impact on Clinical Outcomes.” *Cardiovascular Therapy and Prevention*, 2024. https://doi.org/10.15829/1728-88002024-4015
6. A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, E. V. Privalova, and Y. Belenkov. “Long-Term Effects of Enhanced External Counterpulsation in the Management of Patients with Coronary Artery Disease Complicated by Heart Failure: Data from the EXCEL Study.” *Russian Journal of Cardiology*, 2024. https://doi.org/10.15829/1560-4071-20245886
7. A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, M. F. Petruhnova, E. V. Privalova, and Y. Belenkov. “Long-Term Effects of Enhanced External Counterpulsation in the Management of Patients with Ischemic Chronic Heart Failure.” *Rational Pharmacotherapy in Cardiology*, 2024. https://doi.org/10.20996/1819-6446-2024-3041
8. A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, N. Khabarova, E. Privalova, and Y. Belenkov. “Effectiveness of Different Treatment Regimens of Enhanced External Counterpulsation in Patients with Stable Coronary Artery Disease Complicated by Heart Failure.” *Rational Pharmacotherapy in Cardiology*, 2024. https://doi.org/10.20996/1819-6446-2024-3004
9. A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, and Y. Belenkov. “Cardiovascular Effects of Long-Term Treatment with Enhanced External Counterpulsation in Patients with Ischemic Heart Failure: Randomized, Placebo-Controlled, Open-Label Clinical Trial.” *Journal of Cardiovascular Development and Disease*, 2025. https://doi.org/10.3390/jcdd12090352
10. C. McKenna, C. McDaid, S. Suekarran, N. Hawkins, K. Claxton, K. Light, M. Chester, J. Cleland, N. Woolacott, and M. Sculpher. “Enhanced External Counterpulsation for the Treatment of Stable Angina and Heart Failure: A Systematic Review and Economic Analysis.” *Health Technology Assessment*, 2009. https://doi.org/10.3310/hta13240
11. C. Xiong, and Musheng Yu. “The Influence of External Counterpulsation Technology on Left Ventricular Systolic Function in Patients with Chronic Congestive Heart Failure,” 2016. https://doi.org/10.3760/CMA.J.ISSN.1008-6706.2016.12.013
12. D. Kulchitskaya, T. V. Shovkun, E. V. Yarnykh, T. Konchugova, T. A. Knyazeva, N. V. Gushchina, O. B. Chernyakhovsky, and S. N. Kolbakhova. “[Impact of External Counterpulsation on Microcirculation in Patients with Coronary Heart Disease Complicated by Chronic Heart Failure After Surgical and Endovascular Myocardial Revascularization].” *Voprosy Kurortologii, Fizioterapii i Lechebnoi Fizicheskoi Kultury*, 2019. https://doi.org/10.17116/kurort2019960515
13. Darren T. Beck, Darren P. Casey, Jeffrey S. Martin, Paloma D. Sardina, and R. Braith. “Enhanced External Counterpulsation Reduces Indices of Central Blood Pressure and Myocardial Oxygen Demand in Patients with Left Ventricular Dysfunction.” *Clinical and Experimental Pharmacology and Physiology*, 2015. https://doi.org/10.1111/1440-1681.12367
14. Darren T. Beck, Jeffrey S. Martin, Darren P. Casey, Paloma D. Sardina, and R. Braith. “Enhanced External Counterpulsation Reduces Indices of Left Ventricular Wasted Energy and Myocardial Oxygen Demand in Patients with Left Ventricular Dysfunction and Refractory Angina,” 2015. https://doi.org/10.1096/fasebj.29.1_supplement.952.11
15. Du Zhi-min. “Enhanced External Counterpulsation and Protection of Heart Function: Results from PEECH Trial,” 2009.16. G. Kozdağ, G. Ertas, F. Aygun, E. Emre, A. Kirbaş, D. Ural, and O. Soran. “Clinical Effects of Enhanced External Counterpulsation Treatment in Patients with Ischemic Heart Failure.” *Anadolu Kardiyoloji Dergisi: AKD = the Anatolian Journal of Cardiology*, 2012. https://doi.org/10.5152/akd.2012.064
17. H. Chopra, C. Krishna, R. S. Sambi, K. Aggarwal, S. Parashar, Rakesh Gupta, M. Bansal, et al. “Enhanced External Counterpulsation and CVD Protection: 3D Echo Validation: A Promising Approach.” *Indian Heart Journal*, 2011.
18. I. Shashenkov, S. A. Gabrusenko, S. L. Babak, and A. G. Maliavin. “Clinical Effects of the Enhanced External Counterpulsation Therapy in Patients with Ischemic Chronic Heart Failure Exacerbation COVID-19.” *European Heart Journal*, 2021. https://doi.org/10.1093/eurheartj/ehab724.0928
19. K. S. Karaganov, A. Lishuta, and Y. Belenkov. “The Use of Enhanced External Counterpulsation in the Treatment of Patients with Coronary Artery Disease.” *Rational Pharmacotherapy in Cardiology*, 2020. https://doi.org/10.20996/1819-6446-2020-08-07
20. K. S. Karaganov, O. Slepova, A. Lishuta, N. Solomakhina, and Y. Belenkov. “Medium-Term Effects of Enhanced External Counterpulsation in the Structural and Functional Parameters of Blood Vessels in Patients with Coronary Artery Disease.” *Rational Pharmacotherapy in Cardiology*, 2021. https://doi.org/10.20996/1819-6446-2021-08-03
21. K. Tecson, M. Silver, Sonja Brune, C. Cauthen, M. Kwan, J. Schussler, Anupama Vasudevan, J. Watts, and P. McCullough. “Impact of Enhanced External Counterpulsation on Heart Failure Rehospitalization in Patients With Ischemic Cardiomyopathy.” *American Journal of Cardiology*, 2016. https://doi.org/10.1016/j.amjcard.2015.12.024
22. K. Vijayaraghavan, Lawrence Santora, J. Kahn, N. Abbott, J. Torelli, and G. Vardi. “New Graduated Pressure Regimen for External Counterpulsation Reduces Mortality and Improves Outcomes in Congestive Heart Failure: A Report from the Cardiomedics External Counterpulsation Patient Registry.” *Congestive Heart Failure*, 2005. https://doi.org/10.1111/J.1527-5299.2005.04068.X
23. Lishuta A.S., Nikolaeva N.A., and Belenkov Yu.N. “LONG-TERM EFFECTIVENESS OF ENHANCED EXTERNAL COUNTERPULSATION IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE.” *Medical & Pharmaceutical Journal "Pulse"*, 2024. https://doi.org/10.26787/nydha-2686-6838-2024-26-6-63-70
24. ———. “LONG-TERM VASCULAR EFFECTS OF ENHANCED EXTERNAL CONTROPULSATION IN PATIENTS WITH CORONARY HEART DISEASE COMPLICATED BY HEART FAILURE.” *Medical & Pharmaceutical Journal "Pulse"*, 2024. https://doi.org/10.26787/nydha-2686-6838-2024-26-4-81-89
25. Lishuta A.S., Slepova O.A., Nikolaeva N.A., and Belenkov Yu.N. “MEDIUM-TERM EFFECTS OF ENHANCED EXTERNAL COUNTERPULSATION ON GLYCEMIC CONTROL MARKERS IN PATIENTS WITH CHRONIC.” *Medical & Pharmaceutical Journal "Pulse"*, 2024. https://doi.org/10.26787/nydha-2686-6838-2024-26-5-92-99
26. M. Ege, M. Yılmaz, and O. Soran. “Enhanced External Counterpulsation Therapy Improves Clinical Outcomes, Quality of Life and Functional Effort Capacity in Patients with Symptomatic Heart Failure,” 2015. https://doi.org/10.51261/yiu.2020.00024
27. Maleki Majid, S. Pezeshki, and S. Fereshtehnejad. “COMPARISON BETWEEN MEDICAL MANAGEMENT, ENHANCED EXTERNAL COUNTER PULSATION (EECP) AND CARDIAC RESYNCHRONIZATION THERAPY (CRT) IN HEART FAILURE,” 2008.
28. O. Soran, E. Kennard, S. Kelsey, R. Holubkov, J. Strobeck, and A. Feldman. “Enhanced External Counterpulsation as Treatment for Chronic Angina in Patients with Left Ventricular Dysfunction: A Report from the International EECP Patient Registry (IEPR).” *Congestive Heart Failure*, 2002. https://doi.org/10.1111/J.1527-5299.2002.00286.X
29. S. A. Gabrusenko, V. Malakhov, I. Sergienko, M. E. Bugriĭ, M. Saidova, V. Kukharchuk, and I. Belenkov. “[Novel Possibilities in the Treatment of Patients with Heart Failure. The Method of External Counterpulsation].” *Kardiologiia*, 2008.
30. S. Neill, and M. McIvor. “External Counterpulsation Improves Functional Status in Patients with Ischemic Cardiomyopathy,” 2006. https://doi.org/10.1016/j.cardfail.2006.06.455
31. S. Rampengan, J. Prihartono, Minarma Siagian, and Suzanna Immanuel. “The Effect of Enhanced External Counterpulsation Therapy and Improvement of Functional Capacity in Chronic Heart Failure Patients: A Randomized Clinical Trial.” *Acta Medica Indonesiana*, 2015.
32. Sabapathy Kannappan, and T. Kannappan. “Evaluation of the Role of Enhanced External Counter Pulsation in Patients with Chronic Heart Failure,” 2017. https://doi.org/10.18203/2349-3933.IJAM20173081
33. “The Benefits and Safety of External Counterpulsation in Symptomatic Heart Failure.” *The Israel Medical Association Journal: IMAJ*, 2006.
34. W. Lawson, E. Kennard, J. Hui, and S. Kelsey. “72 ENHANCED EXTERNAL COUNTERPULSATION AS A SYSTEMIC TREATMENT OF DIABETICS WITH ANGINA AND HEART FAILURE.” *Journal of Investigative Medicine*, 2005. https://doi.org/10.2310/6650.2005.00205.71
35. W. Lawson, M. Silver, J. Hui, E. Kennard, and S. Kelsey. “Angina Patients with Diastolic Versus Systolic Heart Failure Demonstrate Comparable Immediate and One-Year Benefit from Enhanced External Counterpulsation.” *Journal of Cardiac Failure*, 2003. https://doi.org/10.1016/J.CARDFAIL.2004.04.006
36. X-L Huang, X. Wang, B-T Chen, and Y-N Chen. “Clinical Efficacy of Enhanced External Counter Pulsation Plus Sacubitril/Valsartan in the Treatment of Patients with Chronic Heart Failure and the Effect on Ankle-Arm Index and Cardiac Function.” *European Review for Medical and Pharmacological Sciences*, 2023. https://doi.org/10.26355/eurrev_202304_32101
37. Y. Belenkov, A. Lishuta, O. A. Slepova, N. A. Nikolaeva, N. Khabarova, G. M. Dadashova, and E. V. Privalova. “The EXCEL Study: Long-Term Observation of the Effectiveness of Drug and Non-Drug Rehabilitation in Patients with Ischemic Heart Failure.” *Kardiologiia*, 2024. https://doi.org/10.18087/cardio.2024.1.n2615
38. Yiliang Yan, Zichen Han, Bowen Zhou, Kui Li, Jintao Hu, Sigong Yang, Jun Zhang, and Xuemin Hu. “Effects of Cardiac Rehabilitation Combined with Enhanced External Counterpulsation on Heart Rate Variability and Autonomic Nervous Function in Chronic Heart Failure.” *Cardiovascular Toxicology*, 2025. https://doi.org/10.1007/s12012-025-10027-1
39. Zhao Zhou, Danyan Wang, Xu-Mei Li, Cheng Zhang, and Chun-Yang Wu. “Effects of Enhanced External Counterpulsation on Exercise Capacity and Quality of Life in Patients with Chronic Heart Failure.” *Medicine*, 2021. https://doi.org/10.1097/MD.0000000000026536
40. Zhi-jian Peng, Jian-sheng Cai, B. Lin, Ji-feng Li, and Shaojin Zhang. “Effects of Enhanced External Counterpulsation in Treatment of the Hypertensive Patients with Diastolic Heart Failure,” 2008. https://doi.org/10.3760/CMA.J.ISSN.1008-6706.2008.12.009